Pathophysiology, diagnosis and current management of chronic constipation

Nature Clinical Practice Gastroenterology and Hepatology

Volumn 3, Issue 2, 2006, Pages 90-100

  Wald, Arnold ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Anorectum; Colon; Constipation; Laxatives; Megacolon

Indexed keywords

ANTHRAQUINONE DERIVATIVE; BISACODYL; BULKING AGENT; CHOLINERGIC RECEPTOR STIMULATING AGENT; CHOLINESTERASE INHIBITOR; CISAPRIDE; COLCHICINE; LACTULOSE; LAXATIVE; MACROGOL; MAGNESIUM DERIVATIVE; METHYLCELLULOSE; METOCLOPRAMIDE; MISOPROSTOL; PHENOLPHTHALEIN; POLYCARBOPHIL CALCIUM; SENNA EXTRACT; SEROTONIN AGONIST; SORBITOL; TEGASEROD;

ABDOMINAL RADIOGRAPHY; AGE DISTRIBUTION; BRAN; CARDIOTOXICITY; CHRONIC DISEASE; CLINICAL PRACTICE; CLINICAL TRIAL; COLONOSCOPY; CONSERVATIVE TREATMENT; CONSTIPATION; COST EFFECTIVENESS ANALYSIS; DEFECATION DISORDER; DEFECOGRAPHY; DEPRESSION; DIET SUPPLEMENTATION; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; HIRSCHSPRUNG DISEASE; HUMAN; INTESTINE TRANSIT TIME; LOW CALORY DIET; MANOMETRY; MEGACOLON; MUSCLE RESECTION; NONHUMAN; PATHOPHYSIOLOGY; PELVIC FLOOR MUSCLE TRAINING; PHYSICAL EXAMINATION; PREVALENCE; PRIORITY JOURNAL; RECTOCELE; REPRODUCIBILITY; REVIEW; RISK ASSESSMENT; RISK FACTOR; SIGMOIDOSCOPY; SOCIOECONOMICS; SURGICAL TECHNIQUE; TREATMENT CONTRAINDICATION; TREATMENT FAILURE; TREATMENT INDICATION; TREATMENT OUTCOME;

CHRONIC DISEASE; CONSTIPATION; DIAGNOSIS, DIFFERENTIAL; GASTROINTESTINAL TRANSIT; HUMANS; RISK FACTORS;

EID: 33645300400     PISSN: 17434378     EISSN: 17434386     Source Type: Journal    
DOI: 10.1038/ncpgasthep0406     Document Type: Review

References (28)

1. Thompson WG et al. (1999) Functional bowel disorders and functional abdominal pain. Gut 45 (Suppl 2): II43-II45
2. Higgins PDR and Johanson JF (2004) Epidemiology of constipation in North America: A systematic review. Am J Gastroenterol 99: 750-759
3. Locke GR et al. (2000) AGA technical review on constipation. American Gastroenterological Association. Gastroenterology 119: 1766-1778
4. Wald A (2005) Constipation and constipation syndromes. In Clinical Gastroenterology and Hepatology: The Modern Clinicians Guide, 443-451 (Eds WM Weinstein et al.) London: Elsevier Science
5. Muller-Lissner S et al. (2005) Myths and misconceptions about chronic constipation. Am J Gastroenterol 100: 232-242
6. Rao SS et al. (2004) Dyssynergic defecation: Demographics, symptoms, stool patterns and quality of life. J Clin Gastroenterol 38: 680-685
7. Preston DM et al. (1985) Towards a radiologic definition of idiopathic megacolon. Gastrointest Radiol 10: 167-169
8. Rao SSC et al. (2005) Clinical utility of diagnostic tests for constipation in adults. Am J Gastroenterol 100: 1605-1615
9. Brandt LJ et al. (2005) Systematic review on the management of chronic constipation in North America. Am J Gastroenterol 100 (Suppl 1): S5-S21
10. Arhan P et al. (1981) Segmental colonic transit time. Dis Colon Rectum 24: 625-629
11. Metcalf AM et al. (1987) Simplified assessment of segmental colonic transit. Gastroenterology 92: 40-47
12. Minguiz M et al. (2004) Predictive value of the balloon expulsion test for excluding the diagnosis of pelvic floor dyssynergia in constipation. Gastroenterology 126: 57-62
13. Diamant NE et al. AGA technical review on anorectal testing techniques. Gastroenterology 116: 735-760
14. Wald A (2005) Severe constipation. Clin Gastroenterol Hepatol 3: 432-435
15. Corazziari E et al. (2000) Long-term efficacy, safety and tolerability of low daily doses of isosmotic polyethylene glycol balanced solution (PMF-100) in treatment of functional chronic constipation. Gut 46: 522-526
16. Johanson J et al. (2004) Effect of tegaserod in chronic constipation: A randomized, double-blind, controlled trial. Clin Gastroenterol Hepatol 2: 796-805
17. Kamm M et al. (2005) Tegaserod for the treatment of chronic constipation: A randomized, double-blind, placebo controlled multinational study. Am J Gastroenterol 100: 372-382
18. Roarty TP et al. (1997) Misoprostol in the treatment of chronic refractory constipation: Results of a long-term open label trial. Aliment Pharmacol Ther 11: 1059-1066
19. Verne GN et al. (2003) Treatment of chronic constipation with colchicine: Randomized, double-blind, placebo controlled crossover trial. Am J Gastroenterol 98: 1112-1116
20. Cheung O and Wald A (2004) Management of pelvic floor disorders. Aliment Pharmacol Ther 19: 481-495
21. Knowles CH et al. (1999) Outcome of colectomy for slow transit constipation. Ann Surg 230: 627-638
22. Gladman MA et al. (2005) Systematic review of surgical options for idiopathic megarectum and megacolon. Ann Surg 241: 562-574
23. O'Suilleabhain CB et al. (2001) Strategy for the surgical management of patients with idiopathic megarectum and megacolon. Br J Surg 88: 1392-1396
24. Heymen S et al. (2003) Biofeedback treatment of constipation: A critical review. Dis Colon Rectum 46: 1208-1217
25. Chiaroni G et al. (2005) Biofeedback benefits only patients with outlet dysfunction, not patients with isolated slow transit constipation. Gastroenterology 129: 86-97
26. Cleveland MV et al. (2001) New polyethylene glycol laxative for treatment of constipation in adults: A randomized, double-blind, placebo-controlled study. South Med J 94: 478-481
27. DiPalma JA et al. (2000) A randomized, placebo-controlled, multicenter study of the safety and efficacy of a new polyethylene glycol laxative. Am J Gastroenterol 95: 446-450
28. Corazziari E et al. (1996) Small volume isosmotic polyethylene glycol electrolyte balanced solution (PMF-100) in treatment of chronic nonorganic constipation. Dig Dis Sci 41: 1636-1642